The Manchester Cancer Research Centre creates a centre for excellence in Cancer research and treatment. The new facility contains the clinical trials unit relocated from The Christie comprising of administration and office accommodation. It is visted by the public and consideration has been made of the NHS Technical memoranda (HTMs). The new facility will contain laboratory accommodation for research groups, write up, in addition to the accommodation for the relocated Clinical Trials Unit from The Christie. The laboratory spaces are contained in three, two storey pavilions, each supported by a third floor plant. The new building will provide essential space and will facilitate the expansion of key research themes by providing space for 150 cancer researchers. As well as the expansion of research activity, the new MCRC research building will also be pivotal in creating a recruitment incentive to attract additional world class researchers in a deeply competitive international marketplace. The base plan arrangement is intended to promote increased interaction between research teams and also contains a bistro and lecture theatre for 150 on the ground floor. The MCRC development is part of a wider masterplan for The Christie site, which also makes provision for a phase 2 MCRC development and future development plans for The Christie.